YB
Yuva Biosciences, Inc.
SEC filingOther · Birmingham, AL
Amount raised$1.1Msold at filing
Total offering$3M$1.9M still open
Investors in the raise11count reported to the SEC
FiledMar 24, 2026first sale Mar 16, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Greg SchmergelExecutive Officer, Director
Fred EhrsamDirector
Daniel BrowneDirector
Executive officers, directors and promoters as listed on the Form D.